These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 12436440

  • 1. Autologous stem cell transplantation for patients with chronic myeloid leukemia. The Argentine Group of Bone Marrow Transplantation (GATMO) experience.
    Koziner B, Dengra C, Lucero G, Klein G, Cánepa C, Milovic V, Milone G, Robinson A, Cerutti I, Saporito G, Kusminsky G, Milone J, Bordone J, Lastiri F, Argentine Group of Bone Marrow Transplantation.
    Cancer; 2002 Dec 01; 95(11):2339-45. PubMed ID: 12436440
    [Abstract] [Full Text] [Related]

  • 2. High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia.
    Kantarjian HM, Talpaz M, Andersson B, Khouri I, Giralt S, Rios MB, Champlin R, Hester J, Deisseroth AB.
    Bone Marrow Transplant; 1994 Jul 01; 14(1):57-61. PubMed ID: 7951120
    [Abstract] [Full Text] [Related]

  • 3. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization.
    Olavarria E, Parker S, Craddock C, Philpott N, Tiniakou M, Chase A, Kanfer E, Apperley JF, Goldman JM.
    Haematologica; 2000 Jun 01; 85(6):647-52. PubMed ID: 10870123
    [Abstract] [Full Text] [Related]

  • 4. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A, Robak T, Pluta A, Zwolińska M, Wawrzyniak E, Wierzbowska A, Skotnicki A, Jakubas B, Hołowiecki J, Nowak K, Kuliczkowski K, Mazur G, Haus O, Dmoszyńska A, Adamczyk-Cioch M, Jedrzejczak WW, Paluszewska M, Konopka L, Pałynyczko G.
    Ann Hematol; 2006 Jun 01; 85(6):366-73. PubMed ID: 16523310
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
    Mittal P, Saliba RM, Giralt SA, Shahjahan M, Cohen AI, Karandish S, Onida F, Beran M, Champlin RE, de Lima M.
    Bone Marrow Transplant; 2004 May 01; 33(10):1005-9. PubMed ID: 15048141
    [Abstract] [Full Text] [Related]

  • 6. Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT.
    Reiffers J, Goldman J, Meloni G, Cahn JY, Gratwohl A.
    Bone Marrow Transplant; 1994 Sep 01; 14(3):407-10. PubMed ID: 7994263
    [Abstract] [Full Text] [Related]

  • 7. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].
    Meng FY, Sun J, Liu QF, Xu D, Yang LJ, Song LL, Liu XL, Xu B, Zhou SY.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec 01; 23(12):1301-2, 1306. PubMed ID: 14678896
    [Abstract] [Full Text] [Related]

  • 8. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 01; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 9. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.
    Meloni G, Russo D, Baccarani M, Testoni N, Martinelli G, Fanin R, Zuffa E, Rosti G, Alimena G, Saglio G, Mandelli F, Tura S.
    Haematologica; 1999 Aug 01; 84(8):707-15. PubMed ID: 10457406
    [Abstract] [Full Text] [Related]

  • 10. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr 01; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

  • 11. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J, Wu B, Liu Q, Feng R, Liu X, Meng F, Zhou S.
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug 01; 21(8):400-2. PubMed ID: 11877009
    [Abstract] [Full Text] [Related]

  • 12. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
    Martins C, Lacerda JF, Lourenço F, Carmo JA, Lacerda JM.
    Acta Med Port; 2005 Aug 01; 18(5):329-37. PubMed ID: 16611537
    [Abstract] [Full Text] [Related]

  • 13. Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemia.
    Konstantinidou P, Szydlo RM, Chase A, Goldman JM.
    Bone Marrow Transplant; 2000 Jan 01; 25(2):143-6. PubMed ID: 10673671
    [Abstract] [Full Text] [Related]

  • 14. Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experience.
    Khouri IF, Kantarjian HM, Talpaz M, Giralt S, Rios MO, Hester JP, Champlin RE, Deisseroth AB.
    Bone Marrow Transplant; 1996 May 01; 17(5):775-9. PubMed ID: 8733697
    [Abstract] [Full Text] [Related]

  • 15. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F, Ball G, Kantarjian HM, Smith TL, Glassman A, Albitar M, Scappini B, Rios MB, Keating MJ, Beran M.
    Cancer; 2002 Oct 15; 95(8):1673-84. PubMed ID: 12365015
    [Abstract] [Full Text] [Related]

  • 16. Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex.
    Rowe JM, Rapoport AP, Ryan DH, Nilsson BI, Duerst RE, Packman CH, Abboud CN, DiPersio JF, Linder T, Wang N, Simonsson B, Liesveld JL.
    Bone Marrow Transplant; 1999 Nov 15; 24(10):1057-63. PubMed ID: 10578155
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK, Parikh PM, Tawde S, Amare-Kadam PS, Rajadhyaksha S, Chhaya S.
    Natl Med J India; 2004 Nov 15; 17(2):71-3. PubMed ID: 15141598
    [Abstract] [Full Text] [Related]

  • 18. Autologous hematopoietic cell transplantation for chronic myelogenous leukemia.
    Bhatia R, McGlave PB.
    Hematol Oncol Clin North Am; 2004 Jun 15; 18(3):715-32, xi. PubMed ID: 15271402
    [Abstract] [Full Text] [Related]

  • 19. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells.
    Deininger MW, Cortes J, Paquette R, Park B, Hochhaus A, Baccarani M, Stone R, Fischer T, Kantarjian H, Niederwieser D, Gambacorti-Passerini C, So C, Gathmann I, Goldman JM, Smith D, Druker BJ, Guilhot F.
    Cancer; 2007 Oct 01; 110(7):1509-19. PubMed ID: 17702093
    [Abstract] [Full Text] [Related]

  • 20. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
    Jiang Q, Chen SS, Jiang B, Jiang H, Lu Y, Qiu JY, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan 01; 26(1):23-6. PubMed ID: 15946504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.